Fourth Pfizer Dose Is Insufficient to Ward Off Omicron, Israeli Trial Suggests

Bloomberg2022-01-18

Preliminary data found inoculation did increase antibodiesThose with 4th shot only slightly less likely to get variantA health worker administers a fourth dose of the Pfizer-BioNTech Covid-19 vaccine ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

PJoo
2022-01-18
PJoo
Human vs virus, who's stronger?

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1137012213?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2022-01-18 16:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137012213","market":"us","top_or_hot":-1,"title":"Fourth Pfizer Dose Is Insufficient to Ward Off Omicron, Israeli Trial Suggests","media":"Bloomberg","content":"<div>\n<p>Preliminary data found inoculation did increase antibodiesThose with 4th shot only slightly less likely to get variantA health worker administers a fourth dose of the Pfizer-BioNTech Covid-19 vaccine ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-01-17/israel-trial-suggests-4th-dose-not-warding-off-omicron-infection?srnd=premium\">网页链接</a>\n\n</div>\n","source":"lsy1584095487587","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fourth Pfizer Dose Is Insufficient to Ward Off Omicron, Israeli Trial Suggests</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFourth Pfizer Dose Is Insufficient to Ward Off Omicron, Israeli Trial Suggests\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-18 16:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2022-01-17/israel-trial-suggests-4th-dose-not-warding-off-omicron-infection?srnd=premium><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Preliminary data found inoculation did increase antibodiesThose with 4th shot only slightly less likely to get variantA health worker administers a fourth dose of the Pfizer-BioNTech Covid-19 vaccine ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2022-01-17/israel-trial-suggests-4th-dose-not-warding-off-omicron-infection?srnd=premium\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"https://www.bloomberg.com/news/articles/2022-01-17/israel-trial-suggests-4th-dose-not-warding-off-omicron-infection?srnd=premium","article_id":"1137012213","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137012213","pubTimestamp":1642493049,"columns":[],"sourceInfo":{"source_id":"lsy1584095487587","name":"Bloomberg"},"weMediaInfo":null,"summary":"Preliminary data found inoculation did increase antibodiesThose with 4th shot only slightly less lik","collect":0,"end_time":0,"defaultTopTitle":"bloomberg.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"PFE":"辉瑞"},"translate_title":"以色列试验表明，第四辉瑞剂量不足以抵御奥密克戎病毒","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":0.9},"content_text":"Preliminary data found inoculation did increase antibodiesThose with 4th shot only slightly less likely to get variantA health worker administers a fourth dose of the Pfizer-BioNTech Covid-19 vaccine at Sheba medical center, in Ramat Gan, Israel, on Dec. 31, 2021.Photographer: Kobi Wolf/BloombergA fourth dose of the Pfizer-BioNTech vaccine was insufficient to prevent infection with the omicron variant of Covid-19, according to preliminary data from a trial in Israel released Monday.Two weeks after the start of the trial of 154 medical personnel at the Sheba Medical Center in Tel Aviv, researchers found the vaccine raised antibody levels.But that only offered a partial defense against omicron, according to Gili Regev-Yochay, the trial’s lead researcher. Vaccines which were more effective against previous variants offer less protection with omicron, she said. Still, those infected in the trial had only slight symptoms or none at all.Last week, European Union regulators warned that frequent Covid-19 booster shots could weaken the immune system and may not be feasible.Israel started rolling out the fourth dose of the vaccine to the over-60s and immunocompromised in late December amid a surge in cases. Since then, more than half a million Israelis have received the extra dose, according to the Health Ministry.The decision to give the fourth vaccine to the most vulnerable was the correct one, Regev-Yochay said at a virtual press conference, because it may have given additional benefit against omicron. But the results didn’t support a wider rollout to the whole population, she added.Researchers at Sheba are also conducting a trial using a fourth dose of the Moderna vaccine on 120 volunteers who had previously received three shots of the Pfizer-BioNTech jab. One week into the trial, they found a similar rise in antibodies to those that had been given four Pfizer doses, according to Regev-Yochay.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":697223174,"gmtCreate":1642495420995,"gmtModify":1642495837062,"author":{"id":"3572863479502236","authorId":"3572863479502236","name":"PJoo","avatar":"https://static.tigerbbs.com/c1df329f4341646fc633446858d34c31","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3572863479502236","authorIdStr":"3572863479502236"},"htmlText":"Human vs virus, who's stronger?&nbsp;","listText":"Human vs virus, who's stronger?&nbsp;","text":"Human vs virus, who's stronger?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697223174","repostId":1137012213,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":6,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1137012213"}